1 / 2

Drug & Gene Delivery Devices Market

The global drug & gene delivery devices market size was valued at USD 533.24 billion in 2020 and is anticipated to reach a significant CAGR during the forecast period, 2021u20132028. The growth of the market is attributed to the rising research on improved drug delivery and high number of new drug delivery system.

Download Presentation

Drug & Gene Delivery Devices Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Drug & Gene Delivery Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast The global drug & gene delivery devices market size was valued atUSD 533.24 billion in 2020 and is anticipated to reach a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising research on improved drug delivery and high number of new drug delivery system. The drug & gene delivery devices are the types of medical equipment that are primarily designed and used to operate the delivery of the drugs and genes for the treatment of the disease. The drug and gene delivery system are applied for the treatment of different disease caused from bacterial infections, malignant tumors, viral invasions, external chemical toxins, and endogenous genetic defects. Drug delivery systems are constantly improving as well as changing choices of the patient. For example, earlier hormone replacement therapy was prescribed as pills, however, it is prescribed in as vaginal rings, patches, gel, prefilled syringes, and sprays. The main purpose of preparing several types of delivery systems is to improve the ease of use. The delivery system is also developed based on the factors such as price, aesthetics of the delivery systems, and amount of API. The recent advancements in the delivery system are development of auto-injectors, development of biopharmaceutical classification systems (BCS) class II oral dosage form drugs, presence of improved implants in customized sizes & shapes, and development of advanced pulmonary devices such as adaptive aerosol delivery and smartcard. Request Sample link :- https://growthmarketreports.com/request-sample/2363 Market Trends, Drivers, Restraints, and Opportunities  Growing funding by the major players to introduce innovative drug delivery systems to supply to the demand of the patients along with to improve the bioavailability at smallest quantity of active pharmaceutical ingredient are propelling the market expansion in the near future.

  2. Rising attention on R&D of gene delivery systems due to the huge growth potential of gene therapy for the treatment of several deadly diseases is proving to boost the market growth. High prevalence of chronic disease across the world and large number of the targeted patients are key factors for the market growth. Low interest of government from developing regions and high cost of development are key challenges that can restrain the market growth in the coming years. High number of diseases in the world and growing preference of improved delivery systems along with growing R&D activities across the world are key opportunities for the market during the forecast period.    Market Segment Insights: Oral segment is expected to grow at a rapid pace Based on drug delivery types, the global drug & gene delivery devices market is divided into injectable, oral, inhalation, ocular, transdermal, nasal, and topical. The oral segment is expected to grow at a rapid pace during the projected period owing to the factors such as ease of use, easy availability, and self-administration. The injectable segment, on the other hand, is expected to grow at significant growth rate in the coming years as the potency is high, increased investments by the biotechnological companies, improved products, and introduction of self-injection. The oral route has a disadvantage of deterioration of drugs that is overcome by the injectable route. Enquiry Link :-https://growthmarketreports.com/enquiry-before-buying/2363 Competitive Landscape Key players competing in the drug & gene delivery devices market are Novartis AG; Pfizer; Inc.; F. Hoffmann-La Roche Ltd; Johnson and Johnson Private Ltd; Bayer AG; and Becton, Dickinson and Company. About Growth Market Reports: GMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. GMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys. Contact: Growth Market Reports Phone: +1 909 414 1393 Email: sales@growthmarketreports.com Web: https://growthmarketreports.com Follow Us: LinkedIn | Twitter

More Related